Crossref Cited-by Linking logo

Collect. Czech. Chem. Commun. 1969, 34, 901-909

Biochemical mechanisms of drug resistance. IX. Metabolic alterations in leukemic mouse cells following 5-aza-2'-deoxycytidine

J. Veselý, A. Čihák and F. Šorm

Crossref Cited-by Linking

  • Requena Cristina E., Pérez-Moreno Guiomar, Horváth András, Vértessy Beáta G., Ruiz-Pérez Luis M., González-Pacanowska Dolores, Vidal Antonio E.: The nucleotidohydrolases DCTPP1 and dUTPase are involved in the cellular response to decitabine. Biochemical Journal 2016, 473, 2635. <>
  • Krečmerová Marcela, Otmar Miroslav: 5-azacytosine compounds in medicinal chemistry: current stage and future perspectives. Future Medicinal Chemistry 2012, 4, 991. <>
  • Parker William B.: Enzymology of Purine and Pyrimidine Antimetabolites Used in the Treatment of Cancer. Chem. Rev. 2009, 109, 2880. <>
  • Christman Judith K: 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene 2002, 21, 5483. <>
  • Adams R.L.P., Fulton J., Kirk D.: The effect of 5-azadeoxycytidine on cell growth and DNA methylation. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 1982, 697, 286. <>
  • Adams R. L. P., Burdon R. H., Herbert Taylor J.: Dna Methylation in Eukaryote. Critical Reviews in Biochemistry 1982, 13, 349. <>
  • Richard L., Momparler, Derse David: Kinetics of phosphorylation of 5-aza-2′-deoxycytidine by deoxycytidine kinase. Biochemical Pharmacology 1979, 28, 1443. <>
  • Veselý Jiří, Čihák Alois: 5-Azacytidine: Mechanism of action and biological effects in mammalian cells. Pharmacology & Therapeutics. Part A: Chemotherapy, Toxicology and Metabolic Inhibitors 1978, 2, 813. <>
  • Durham John P., Ives David H.: Deoxycytidine Kinase. Journal of Biological Chemistry 1970, 245, 2276. <>
  • Doskocil J., Sorm F.: The Mode of Action of 5-Aza-2'-Deoxycytidine in Escherichia coli. Eur J Biochem 1970, 13, 180. <>